TY  - JOUR
AU  - Marañon, Patricia
AU  - Fernandez-Garcia, Carlos Ernesto
AU  - Isaza, Stephania C
AU  - Rey, Esther
AU  - Gallego-Duran, Rocio
AU  - Montero-Vallejo, Rocio
AU  -  Rodriguez-de-Cia, Javier
AU  - Ampuero, Javier
AU  - Romero-Gomez, Manuel
AU  - Garcia-Monzon, Carmelo
AU  - Gonzalez-Rodriguez, Agueda
PY  - 2022
DO  - 10.1186/s40364-022-00383-3
SN  - 2050-7771
UR  - http://hdl.handle.net/10668/20372
T2  - Biomarker research
AB  - Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide, being non-alcoholic steatohepatitis (NASH) its most clinically relevant form. Given the risks associated with taking a liver biopsy, the design of...
LA  - en
KW  - BMP2
KW  - Bone morphogenetic proteins
KW  - Hepatocytes
KW  - Non-alcoholic fatty liver disease
KW  - Non-invasive diagnosis
KW  - Humans
KW  - Non-alcoholic Fatty Liver Disease
KW  - Palmitic Acid
KW  - Biopsy
KW  - Hepatocytes
KW  - Homeostasis
KW  - Algorithms
TI  - Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
TY  - research article
VL  - 10
ER  -